No relation between in-utero exposure to HAART and intrauterine growth retardation

AIDS

Volumn 23, Issue 10, 2009, Pages 1235-1243

  Briand, Nelly ^a,b   Mandelbrot, Laurent ^a,c,d   Chenadec, Jérôme Le ^a,b   Tubiana, Roland ^a,e   Teglas, Jean Paul ^a,b   Faye, Albert ^f   Dollfus, Catherine ^g   Rouzioux, Christine ^c,h   Blanche, Stéphane ^c,h   Warszawski, Josiane ^a,i,j  

^a INSERM   (France)

^b INSTITUT NATIONAL D'ÉTUDES DÉMOGRAPHIQUES   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL LOUIS MOURIER   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f HÔPITAL ROBERT DEBRÉ   (France)

^g ARMAND TROUSSEAU HOSPITAL   (France)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

ⁱ UNIVERSITÉ PARIS SACLAY   (France)

^j BICÊTRE HOSPITAL   (France)

more..

Author keywords

Birth weight; HAART; Mother to child hiv transmission; Small for gestational age; Z scores adjusted for gestational age and sex

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; BIRTH WEIGHT; BODY HEIGHT; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MONOTHERAPY; NEWBORN; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRENATAL EXPOSURE; PRIORITY JOURNAL; TREATMENT DURATION;

ADULT; ANTHROPOMETRY; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIRTH WEIGHT; COHORT STUDIES; FEMALE; FETAL GROWTH RETARDATION; FRANCE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PRENATAL EXPOSURE DELAYED EFFECTS; YOUNG ADULT;

EID: 67651111907     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32832be0df     Document Type: Article

References (25)

1. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002; 29:484-494.
2. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, Berrebi A, BeniflaJL, Burgard M, et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 2001;285:2083- 2093.
3. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005;40:458-465.
4. loannidis JP, Abrams EJ, Ammann A, Bulterys M, Goedert JJ, Gray L, et al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000copies/ml. J Infect Dis 2001;183:539-545.
5. Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 2008; 22:289-299.
6. Yeni P. Prise en charge médicale des personnes infectées par le VIH. Recommandations du groupe d'experts: Ministere de la Santé et des Solidarités: Paris;2008.
7. Thorne C, Patel D, Newell ML. Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS 2004;18:2337-2341.
8. Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA. Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS 2007;21:1019-1026.
9. Lorenzi P, SpicherVM, Laubereau B, Hirschel B, KindC, Rudin C, et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study. AIDS 1998;12:F241- F247.
10. European Collaborative Study. Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. J Acquir Immune Defic Syndr 2003;32:380-387.
11. Tuomala RE, Shapiro DE, Mofenson LM, Bryson Y, Culnane M, Hughes MD, et al. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 2002;346:1863-1870.
12. Tuomala RE, Watts DH, Li D, Vajaranant M, Pitt J, Hammill H, et al. Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy. J Acquir Immune Defic Syndr 2005;38:449-473.
13. Szyld E, Warley E, Freimanis L, Gonin R, Cahn P, Calvet G, etal. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth. AIDS 2006; 20:2345-2353.
14. Boer K, Nellen JF, Patel D, Timmermans S, Tempelman C, Wibaut M, et al. The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretro- viral therapy and a policy of vaginal delivery. BJOG 2007;114:148-155.
15. European Collaborative Study. Is zidovudine therapy in pregnant HIV-infected women associated with gestational age and birthweight? AIDS 1998;13:119-124.
16. Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, et al. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Cote d'Ivoire. AIDS 2008;22:1815-1820.
17. Cotter AM, Garcia AG, Duthely ML, Luke B, O'Sullivan MJ. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? J Infect Dis 2006;193:1195-1201.
18. Schulte J, Dominguez K, Sukalac T, Bohannon B, Fowler MG. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: pediatric spectrum of HIV disease, 1989-2004. Pediatrics 2007; 119:e900-e906.
19. McKinney RE Jr, Robertson JW. Effect of human immunodeficiency virus infection on the growth of young children. Duke Pediatric AIDS Clinical Trials Unit. J Pediatr 1993; 123:579-582.
20. European Collaborative Study. Weight, height and human immunodeficiency virus infection in young children of infected mothers. Pediatr Infect Dis J 1995;14:685-690.
21. Newell ML, Borja MC, Peckham C. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. Pediatrics 2003;111:e52-e60.
22. Association des Utilisateurs de Dossiers Informatisesen Pedia- trie Obstetrique et Gynecologie. AUDIPOG. [Cited 15 October 2008];http://audipog. inserm.fr/Accueil.php.
23. Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-Octo- ber 1, 2001. Pediatrics 2003;111 (6 Pt 1):1253-1261.
24. Blondel B, Supernant K, du Mazaubrun C, Breart G, Unite de Recherches Epidemiologiques en Sante Peerinatale et Sante des femmes Inserm U149 Enquete Nationale Peerinatale - 2003. [Cited 15 October 2008];http://www.sante.gouv.fr/ htm/dos- siers/perinat03/description.htm#6.
25. Association des Utilisateurs de Dossiers Informatisesén Pédia- trie Obstétrique et Gynecologie. La Santé Perinatale en 2002-2003. Évaluation des pratiques médicales. [Cited 15 October 2008];http://www.audipog.net/pdf/cahier-2002-2003.pdf.